ENVELA CORP (ELA) Fundamental Analysis & Valuation

NYSEARCA:ELA • US29402E1029

12.6 USD
-0.66 (-4.98%)
Last: Mar 6, 2026, 08:13 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ELA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Taking everything into account, ELA scores 7 out of 10 in our fundamental rating. ELA was compared to 124 industry peers in the Specialty Retail industry. ELA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ELA is growing strongly while it is still valued neutral. This is a good combination! These ratings would make ELA suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

7

1. ELA Profitability Analysis

1.1 Basic Checks

  • ELA had positive earnings in the past year.
  • ELA had a positive operating cash flow in the past year.
  • ELA had positive earnings in each of the past 5 years.
  • ELA had a positive operating cash flow in each of the past 5 years.
ELA Yearly Net Income VS EBIT VS OCF VS FCFELA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

  • With an excellent Return On Assets value of 10.31%, ELA belongs to the best of the industry, outperforming 86.18% of the companies in the same industry.
  • With a decent Return On Equity value of 14.77%, ELA is doing good in the industry, outperforming 73.98% of the companies in the same industry.
  • ELA has a better Return On Invested Capital (11.43%) than 80.49% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ELA is in line with the industry average of 13.62%.
Industry RankSector Rank
ROA 10.31%
ROE 14.77%
ROIC 11.43%
ROA(3y)13.47%
ROA(5y)14.62%
ROE(3y)21.28%
ROE(5y)27.31%
ROIC(3y)12.62%
ROIC(5y)13.55%
ELA Yearly ROA, ROE, ROICELA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

  • The Profit Margin of ELA (4.30%) is better than 73.17% of its industry peers.
  • ELA's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 5.18%, ELA is in the better half of the industry, outperforming 68.29% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ELA has grown nicely.
  • ELA has a worse Gross Margin (23.68%) than 73.98% of its industry peers.
  • ELA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.18%
PM (TTM) 4.3%
GM 23.68%
OM growth 3Y-12.44%
OM growth 5Y2.74%
PM growth 3Y-19.3%
PM growth 5Y2.02%
GM growth 3Y3.52%
GM growth 5Y4.39%
ELA Yearly Profit, Operating, Gross MarginsELA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. ELA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ELA is creating some value.
  • The number of shares outstanding for ELA has been reduced compared to 1 year ago.
  • The number of shares outstanding for ELA has been reduced compared to 5 years ago.
  • Compared to 1 year ago, ELA has an improved debt to assets ratio.
ELA Yearly Shares OutstandingELA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ELA Yearly Total Debt VS Total AssetsELA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • ELA has an Altman-Z score of 12.10. This indicates that ELA is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 12.10, ELA belongs to the best of the industry, outperforming 97.56% of the companies in the same industry.
  • ELA has a debt to FCF ratio of 1.73. This is a very positive value and a sign of high solvency as it would only need 1.73 years to pay back of all of its debts.
  • ELA has a Debt to FCF ratio of 1.73. This is in the better half of the industry: ELA outperforms 78.05% of its industry peers.
  • ELA has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of ELA (0.17) is better than 65.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.73
Altman-Z 12.1
ROIC/WACC1.19
WACC9.62%
ELA Yearly LT Debt VS Equity VS FCFELA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

2.3 Liquidity

  • ELA has a Current Ratio of 4.58. This indicates that ELA is financially healthy and has no problem in meeting its short term obligations.
  • ELA has a Current ratio of 4.58. This is amongst the best in the industry. ELA outperforms 97.56% of its industry peers.
  • A Quick Ratio of 2.36 indicates that ELA has no problem at all paying its short term obligations.
  • ELA has a Quick ratio of 2.36. This is amongst the best in the industry. ELA outperforms 90.24% of its industry peers.
Industry RankSector Rank
Current Ratio 4.58
Quick Ratio 2.36
ELA Yearly Current Assets VS Current LiabilitesELA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. ELA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 66.67% over the past year.
  • ELA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.12% yearly.
  • Looking at the last year, ELA shows a small growth in Revenue. The Revenue has grown by 2.92% in the last year.
  • Measured over the past years, ELA shows a quite strong growth in Revenue. The Revenue has been growing by 17.07% on average per year.
EPS 1Y (TTM)66.67%
EPS 3Y-12.25%
EPS 5Y20.12%
EPS Q2Q%116.67%
Revenue 1Y (TTM)2.92%
Revenue growth 3Y8.56%
Revenue growth 5Y17.07%
Sales Q2Q%22.37%

3.2 Future

  • The Earnings Per Share is expected to grow by 28.89% on average over the next years. This is a very strong growth
  • ELA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.97% yearly.
EPS Next Y68.47%
EPS Next 2Y29.56%
EPS Next 3Y28.89%
EPS Next 5YN/A
Revenue Next Year23.19%
Revenue Next 2Y12.35%
Revenue Next 3Y13.97%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ELA Yearly Revenue VS EstimatesELA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
ELA Yearly EPS VS EstimatesELA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. ELA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 31.50 indicates a quite expensive valuation of ELA.
  • ELA's Price/Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Earnings ratio is at 26.29. ELA is around the same levels.
  • Based on the Price/Forward Earnings ratio of 30.02, the valuation of ELA can be described as expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ELA.
  • The average S&P500 Price/Forward Earnings ratio is at 24.57. ELA is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 31.5
Fwd PE 30.02
ELA Price Earnings VS Forward Price EarningsELA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ELA is valued a bit more expensive than 62.60% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as ELA.
Industry RankSector Rank
P/FCF 43.43
EV/EBITDA 27.79
ELA Per share dataELA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • ELA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of ELA may justify a higher PE ratio.
  • ELA's earnings are expected to grow with 28.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.46
PEG (5Y)1.57
EPS Next 2Y29.56%
EPS Next 3Y28.89%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ELA Dividend Analysis

5.1 Amount

  • ELA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ELA Fundamentals: All Metrics, Ratios and Statistics

ENVELA CORP

NYSEARCA:ELA (3/6/2026, 8:13:59 PM)

12.6

-0.66 (-4.98%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-05
Earnings (Next)04-01
Inst Owners18.06%
Inst Owner Change10.78%
Ins Owners49.49%
Ins Owner Change0.04%
Market Cap327.10M
Revenue(TTM)180.38M
Net Income(TTM)8.53M
Analysts80
Price Target13.26 (5.24%)
Short Float %2.37%
Short Ratio1.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)54.5%
Min EPS beat(2)41.44%
Max EPS beat(2)67.56%
EPS beat(4)4
Avg EPS beat(4)44.08%
Min EPS beat(4)18.81%
Max EPS beat(4)67.56%
EPS beat(8)6
Avg EPS beat(8)21.46%
EPS beat(12)8
Avg EPS beat(12)27.4%
EPS beat(16)12
Avg EPS beat(16)29.08%
Revenue beat(2)2
Avg Revenue beat(2)9.1%
Min Revenue beat(2)2.14%
Max Revenue beat(2)16.06%
Revenue beat(4)4
Avg Revenue beat(4)14.28%
Min Revenue beat(4)2.14%
Max Revenue beat(4)21.16%
Revenue beat(8)6
Avg Revenue beat(8)5.22%
Revenue beat(12)9
Avg Revenue beat(12)5.09%
Revenue beat(16)12
Avg Revenue beat(16)8.2%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)16.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.11%
Valuation
Industry RankSector Rank
PE 31.5
Fwd PE 30.02
P/S 1.65
P/FCF 43.43
P/OCF 29.98
P/B 5.66
P/tB 6.49
EV/EBITDA 27.79
EPS(TTM)0.4
EY3.17%
EPS(NY)0.42
Fwd EY3.33%
FCF(TTM)0.29
FCFY2.3%
OCF(TTM)0.42
OCFY3.34%
SpS7.64
BVpS2.23
TBVpS1.94
PEG (NY)0.46
PEG (5Y)1.57
Graham Number4.48
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 14.77%
ROCE 14.62%
ROIC 11.43%
ROICexc 16.93%
ROICexgc 20.06%
OM 5.18%
PM (TTM) 4.3%
GM 23.68%
FCFM 3.8%
ROA(3y)13.47%
ROA(5y)14.62%
ROE(3y)21.28%
ROE(5y)27.31%
ROIC(3y)12.62%
ROIC(5y)13.55%
ROICexc(3y)17.69%
ROICexc(5y)18.43%
ROICexgc(3y)21.62%
ROICexgc(5y)22.7%
ROCE(3y)16.14%
ROCE(5y)17.45%
ROICexgc growth 3Y-9.57%
ROICexgc growth 5Y-0.97%
ROICexc growth 3Y-7.64%
ROICexc growth 5Y1.09%
OM growth 3Y-12.44%
OM growth 5Y2.74%
PM growth 3Y-19.3%
PM growth 5Y2.02%
GM growth 3Y3.52%
GM growth 5Y4.39%
F-Score7
Asset Turnover2.4
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.73
Debt/EBITDA 0.8
Cap/Depr 192.86%
Cap/Sales 1.7%
Interest Coverage 26.86
Cash Conversion 90.66%
Profit Quality 88.29%
Current Ratio 4.58
Quick Ratio 2.36
Altman-Z 12.1
F-Score7
WACC9.62%
ROIC/WACC1.19
Cap/Depr(3y)141.77%
Cap/Depr(5y)313.83%
Cap/Sales(3y)1.17%
Cap/Sales(5y)2.18%
Profit Quality(3y)69.25%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.67%
EPS 3Y-12.25%
EPS 5Y20.12%
EPS Q2Q%116.67%
EPS Next Y68.47%
EPS Next 2Y29.56%
EPS Next 3Y28.89%
EPS Next 5YN/A
Revenue 1Y (TTM)2.92%
Revenue growth 3Y8.56%
Revenue growth 5Y17.07%
Sales Q2Q%22.37%
Revenue Next Year23.19%
Revenue Next 2Y12.35%
Revenue Next 3Y13.97%
Revenue Next 5YN/A
EBIT growth 1Y31.97%
EBIT growth 3Y-4.94%
EBIT growth 5Y20.28%
EBIT Next Year89.14%
EBIT Next 3Y35.84%
EBIT Next 5YN/A
FCF growth 1Y49.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.33%
OCF growth 3Y53.73%
OCF growth 5YN/A

ENVELA CORP / ELA FAQ

What is the fundamental rating for ELA stock?

ChartMill assigns a fundamental rating of 7 / 10 to ELA.


What is the valuation status for ELA stock?

ChartMill assigns a valuation rating of 4 / 10 to ENVELA CORP (ELA). This can be considered as Fairly Valued.


What is the profitability of ELA stock?

ENVELA CORP (ELA) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for ELA stock?

The Price/Earnings (PE) ratio for ENVELA CORP (ELA) is 31.5 and the Price/Book (PB) ratio is 5.66.


What is the earnings growth outlook for ENVELA CORP?

The Earnings per Share (EPS) of ENVELA CORP (ELA) is expected to grow by 68.47% in the next year.